Reimagining what has gone before to create lateral flow test devices that are simpler to use

At Atomo Diagnostics we are transforming rapid diagnostic testing (RDT) through the design and manufacture of innovative blood-based medical devices that have won the respect of frontline healthcare providers worldwide for their usability, reliability and safety.

Professional Use – POCT – Self-Test – OTC

awards-2

NG Test Blood Precision hCG

Award-winning integrated HIV tests

The innovative, user-centred design of the AtomoRapid™ HIV professional use removes the need for multiple test components by integrating them into the device platform – greatly simplifying the test procedure, reducing user errors and improving test accuracy.

Find out more >

Custom device development

Compatible with many different assay formats that utilise blood, Atomo’s patented all-in-one device platforms provide a low-risk, cost-effective commercialisation pathway for OEM partners to launch new diagnostic test applications or enhance their existing RDT product offerings.

Learn more >

Supporting better Global Health outcomes

Recognised by key global health partners for the contribution the company is making to supporting early diagnosis of HIV, as well as its commitment to simplicity in device design, Atomo is spearheading the development of the next generation of HIV self-test products.

Discover more >

shield2

Built-in safety

Auto-retracting lancet activates on contact to lock the needle inside the device for safe disposal, preventing hazardous sharps injuries and the risk of cross-infection.

thumbsup

Easy to use

Easy to use blood collection unit is designed to collect exactly the right sample volume, improving patient comfort and ensuring optimal test performance.

Excellent Quality

Manufactured to the highest international quality standards, including ISO 9001 and ISO 13485, to ensure excellent product performance and reliability.

 Latest Updates

 Press Release

102, 2017

Atomo Diagnostics receives further international financing

SYDNEY, Australia, 1 February  2017: Medical device innovator Atomo Diagnostics today announced it had received US$1 million (A$1.31 million, C$1.32 million) [...]

 News

Canadian Government Fund Invests in Atomo

February 20th, 2017|0 Comments

Delighted to welcome new investors for 2017, earlier this month Atomo Diagnostics announced backing from Grand Challenges Canada (GCC). Investment from the Canadian Government-funded agency totalling US$1 million (A$1.31 million, C$1.32 million), in recognition of [...]

 Blog

World AIDS Day 2016 and the importance of Self-Testing

Written by John Kelly, CEO at Atomo Diagnostics: On 1st December 1988, people from around the world united for the first ever Global Health day in the fight against HIV. World AIDS Day has remained [...]